Ascend Wellness Holdings (AAWH) Inventory Average (2021 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Inventory Average came in at $85.9 million in Q1 2026, down 1.88% year-on-year from $87.6 million in Q1 2025, and up 2.67% quarter-over-quarter from $83.7 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Inventory Average (2021 - 2026) Analysis & Trends
Ascend Wellness Holdings' Inventory Average history runs 6 years deep, the most recent figure standing at $85.9 million for Q1 2026.
- On a quarterly basis, Inventory Average fell 1.88% year-over-year to $85.9 million in Q1 2026; TTM through Mar 2026 was $85.9 million, a 1.88% decrease from a year earlier, with the FY2025 full-year figure at $87.1 million, down 5.73% from the prior year.
- Inventory Average improved to $85.9 million in Q1 2026 per AAWH's latest filing, from $83.7 million in the prior quarter.
- Across five years, Inventory Average topped out at $105.3 million in Q2 2024 and bottomed at $71.9 million in Q1 2022.
- The 5-year median for Inventory Average is $89.8 million (2022), against an average of $90.4 million.
- Across the five-year window, Inventory Average jumped 112.7% in 2022 and decreased 20.29% in 2025, its largest moves.
- Year by year, Inventory Average stood at $94.8 million in 2022, then declined by 2.75% to $92.2 million in 2023, then rose by 1.38% to $93.5 million in 2024, then decreased by 10.46% to $83.7 million in 2025, then gained by 2.67% to $85.9 million in 2026.
- Per Business Quant, the three latest AAWH Inventory Average figures stand at $85.9 million (Q1 2026), $83.7 million (Q4 2025), and $82.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 180.70 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Ascend Wellness Holdings | 78.95 Mn | 18.03 Mn | 44.88 Mn | 85.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85.93 Mn |
| Dec 31, 2025 | 83.69 Mn |
| Sep 30, 2025 | 82.50 Mn |
| Jun 30, 2025 | 83.95 Mn |
| Mar 31, 2025 | 87.57 Mn |
| Dec 31, 2024 | 93.47 Mn |
| Sep 30, 2024 | 100.61 Mn |
| Jun 30, 2024 | 105.32 Mn |
| Mar 31, 2024 | 101.06 Mn |
| Dec 31, 2023 | 92.19 Mn |
| Sep 30, 2023 | 89.32 Mn |
| Jun 30, 2023 | 93.96 Mn |
| Mar 31, 2023 | 97.95 Mn |
| Dec 31, 2022 | 94.80 Mn |
| Sep 30, 2022 | 89.78 Mn |
| Jun 30, 2022 | 82.86 Mn |
| Mar 31, 2022 | 71.91 Mn |
| Dec 31, 2021 | 60.80 Mn |
| Sep 30, 2021 | 51.55 Mn |
| Jun 30, 2021 | 42.86 Mn |